Securities code: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) securities abbreviation: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) Announcement No.: 2022010
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)
Public issuance of convertible corporate bonds
Announcement on the success rate of online issuance and priority placement results
Sponsor (lead underwriter): Zhongtai Securities Co.Ltd(600918)
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
hot tip
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) (hereinafter referred to as ” Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) ,” company “or” issuer “) and Zhongtai Securities Co.Ltd(600918) (hereinafter referred to as” sponsor (lead underwriter) “or” Zhongtai Securities Co.Ltd(600918) “) in accordance with the securities law of the people’s Republic of China, the measures for the administration of securities issuance by listed companies and the measures for the administration of securities issuance and underwriting (order of the CSRC [No. 144]) Detailed rules for the implementation of convertible corporate bond issuance of Shenzhen Stock Exchange (revised in December 2018) (hereinafter referred to as “detailed rules for the implementation”) Shenzhen Stock Exchange Guidelines for business handling of listed companies No. 5 – issuance of convertible corporate bonds to unspecified objects and other relevant provisions publicly issue convertible corporate bonds (hereinafter referred to as “convertible bonds” or “Panlong convertible bonds”).
This offering adopts the priority placement to the original shareholders registered by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch (hereinafter referred to as “CSDCC Shenzhen Branch”) after the closing of the stock market on the equity registration date (March 2, 2022, t-1), The balance after the preferential placement of the original shareholders (including the part that the original shareholders give up the preferential placement) is issued to the public investors online through the trading system of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”). Please read the announcement of the exchange and SZSE (www.szse. Com) The promulgated implementation rules.
The important tips for the issuance process, subscription, payment and disposal of investors’ abandonment are as follows: 1. After online investors win the bid for convertible bonds, It shall fulfill the obligation of capital settlement in accordance with the announcement of online winning results of public issuance of convertible corporate bonds by Shaanxi Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) Group Co., Ltd. (hereinafter referred to as the announcement of online winning results), and ensure that its capital account has sufficient subscription funds on March 7 (T + 2) 2022, The transfer of investors’ funds shall comply with the relevant provisions of the securities company where the investors are located. If the investor’s subscription fund is insufficient, the insufficient part shall be deemed as giving up the subscription, and the resulting consequences and relevant legal liabilities shall be borne by the investor. According to the relevant regulations of CSDCC Shenzhen Branch, the minimum unit to give up subscription is 1 piece. The part that online investors give up subscription shall be underwritten by the sponsor (lead underwriter).
Investors shall reasonably determine the purchase amount in combination with the regulatory requirements of the industry and the corresponding asset scale or capital scale. If the sponsor (lead underwriter) finds that the investor fails to comply with the industrial regulatory requirements and applies for purchase beyond the corresponding asset scale or capital scale, the sponsor (lead underwriter) has the right to determine that the investor’s subscription is invalid. Investors shall express their purchase intention independently and shall not fully entrust securities companies to purchase on their behalf.
2. When the total number of convertible bonds subscribed by the original shareholders and the number of convertible bonds subscribed by online investors is less than 70% of the number of this issue; Or when the total number of convertible bonds preferentially subscribed by the original shareholders and the number of convertible bonds paid and subscribed by online investors are less than 70% of the number of this issuance, the issuer and the recommendation institution (lead underwriter) will negotiate whether to take measures to suspend the issuance, and timely report to the China Securities Regulatory Commission (hereinafter referred to as “CSRC”) and Shenzhen Stock Exchange; If the issuance is suspended, announce the reasons for the suspension and choose the opportunity to restart the issuance.
The part of the subscription amount of this offering less than 276 million yuan shall be underwritten by the sponsor (lead underwriter). The underwriting base of this issuance is 276 million yuan. The recommendation institution (lead underwriter) shall determine the final placement result and underwriting amount according to the online capital arrival. In principle, the underwriting proportion of the recommendation institution (lead underwriter) shall not exceed 30% of the total issuance, that is, in principle, the maximum underwriting amount is 82.8 million yuan. When the actual underwriting ratio exceeds 30% of the total amount of this offering, the sponsor (lead underwriter) will start the internal underwriting risk assessment procedure and negotiate with the issuer: if it is determined to continue to perform the issuance procedure, the sponsor (lead underwriter) will adjust the final underwriting ratio and fully underwrite the amount less than the subscription amount of investors, And report to China Securities Regulatory Commission and Shenzhen Stock Exchange in time; If it is determined to take measures to suspend the issuance, the sponsor (lead underwriter) and the issuer will timely report to the CSRC and the Shenzhen Stock Exchange, announce the reasons for the suspension of the issuance, and choose an opportunity to restart the issuance within the validity period of the approval.
3. If an online investor has won the lottery for 3 times but failed to pay in full within 12 consecutive months, it shall not participate in the subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day of the settlement participant’s latest declaration of abandonment of subscription.
The situation of abandoning subscription shall be judged by investors. The number of times of abandonment of subscription shall be calculated according to the cumulative number of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds actually abandoned by investors; If an investor holds multiple securities accounts and abandons subscription in any one of the securities accounts, the number of times of abandonment shall be calculated cumulatively. The situations of abandonment of subscription occurred in disqualification and cancellation of securities accounts are also included in the statistics.
For the special account for directional asset management and enterprise annuity account of customers of securities companies, if the “account holder’s name” and “valid identity document number” in the registration data of securities accounts are the same, statistics shall be made according to different investors.
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) publicly issued 276 million yuan of convertible corporate bonds. The preferential placement and online subscription of the original shareholders have ended on March 3, 2022 (t day).
According to the announcement of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) public offering of convertible corporate bonds (hereinafter referred to as the “issuance announcement”) published on March 1, 2022 (T-2), this announcement will be published once
It shall be deemed that the allocated information is delivered to all investors participating in the subscription. The results of this issuance and subscription of Panlong convertible bonds are hereby announced as follows:
1、 General situation
Panlong convertible bonds issued this time are 276 million yuan, and the issuing price is 100 yuan each, totaling 2760000 pieces. The priority placement date and online issuance date of the original shareholders of this issuance are March 3, 2022 (t date).
2、 Priority placement results to original shareholders
The original shareholders gave priority to placing 2216811 Panlong convertible bonds, totaling 22168110000 yuan, accounting for 80.32% of the total issued this time.
3、 Online subscription results and successful issuance rate of social public investors
The final online issuance of Panlong convertible bonds to public investors is 543180, totaling 5431800000 yuan, accounting for 19.68% of the total issuance, and the online winning rate is Shenzhen Textile (Holdings) Co.Ltd(000045) 37589%. According to the online subscription information provided by Shenzhen Stock Exchange, the number of valid subscriptions issued online to public investors is 119706739940, the total number of allotments is 11970673994, and the starting and ending numbers are 000000 Ping An Bank Co.Ltd(000001) 011970673994.
The issuer and the recommendation institution (lead underwriter) will organize a lottery ceremony on March 4, 2022 (T + 1), and the lottery results will be published in China Securities Journal and cninfo.com on March 7, 2022 (T + 2)( http://www.cn.info.com.cn. )Make an announcement on the Internet. Investors shall confirm the number of convertible bonds subscribed according to the winning lot number. Each winning lot number can only buy 10 (i.e. 1000 yuan) Panlong convertible bonds.
4、 The placement results of this offering are summarized as follows:
Category effective subscription quantity (piece) actual allocated quantity (piece) winning rate / placing proportion
Original shareholder 221681110000%
Online social public investors 11970673994054318 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 537589%
Total 119708956751275991 –
Note: as stipulated in the issuance announcement, each of the first placement to the original shareholders is one subscription unit, and each of the 10 online subscription units is one subscription unit. Therefore, the balance of 9 sheets is underwritten by the sponsor (lead underwriter). 5、 Time to market
The listing time of Panlong convertible bonds issued this time will be announced separately.
6、 Documents for future reference
For the general information of this offering, please refer to the issuance announcement published on March 1, 2022 (T-2). Investors can also visit cninfo( http://www.cn.info.com.cn. )Query the full text of the prospectus and relevant information about the offering.
7、 Issuer and sponsor (lead underwriter)
1. Issuer: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)
Address: No. 2801, Baliu Second Road, Baqiao District, Xi’an, Shaanxi
Tel: 029833388888832
Contact: Wu Jie
2. Sponsor (lead underwriter): Zhongtai Securities Co.Ltd(600918)
Address: No. 86, Jingqi Road, Shizhong District, Jinan, Shandong
Tel: 01059013948, 01059013949
Contact: capital market department
Issuer: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) sponsor (lead underwriter): Zhongtai Securities Co.Ltd(600918) March 4, 2022
Issuer: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) March 4, 2022 (there is no text on this page, which is the seal page of the announcement on the success rate and preferential placement results of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) public offering of convertible corporate bonds online)
Sponsor (lead underwriter): Zhongtai Securities Co.Ltd(600918) March 4, 2022